Noodles & Company Announces Private Placement Financing
Mar 14, 2017 12:31 pm UTC| Business
BROOMFIELD, Colo., March 14, 2017 -- Noodles Company (the "Company") (NASDAQ:NDLS) today announced a $31.5 million private placement of Class A common stock to Mill Road Capital II, L.P. (“Mill Road”) on March 13, 2017...
Mar 14, 2017 12:31 pm UTC| Business
NEW YORK, March 14, 2017 -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that the Company’s clinical trial...
Mar 14, 2017 12:31 pm UTC| Business
NEW YORK, March 14, 2017 -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that the Company’s clinical trial...
Elev8 Brands, Inc. Introduces French Vanilla and Hazelnut to Hemp Coffee Line
Mar 14, 2017 12:31 pm UTC| Business
ROCKLEDGE, Fla., March 14, 2017 -- Elev8 Brands, Inc. (OTC Pink:VATE) a company with a new premium hemp seed coffee blend, that also plans to bring to market hemp water products and supplements, all of which focus on...
Elev8 Brands, Inc. Introduces French Vanilla and Hazelnut to Hemp Coffee Line
Mar 14, 2017 12:31 pm UTC| Business
ROCKLEDGE, Fla., March 14, 2017 -- Elev8 Brands, Inc. (OTC Pink:VATE) a company with a new premium hemp seed coffee blend, that also plans to bring to market hemp water products and supplements, all of which focus on...
Mar 14, 2017 12:31 pm UTC| Business
MADISON, Wis., March 14, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces the Japanese Patent Office has granted a composition...
Mar 14, 2017 12:31 pm UTC| Business
MADISON, Wis., March 14, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces the Japanese Patent Office has granted a composition...